About Bhami
Bhami is a company based in Mangaluru (India) founded in 2013 by Suryakanth Pai, Naveen Prabhu, Bhami Chennakeshava Shenoy, and Suryakanth Motilal Pai. Bhami has raised $2.41 million across 4 funding rounds from investors including Capitalbiologics, Anoop Venkat Rao and Prajnya Rao. Bhami offers products and services including HILOPRO® and Evopep.
- Headquarter Mangaluru, India
- Founders Suryakanth Pai, Naveen Prabhu, Bhami Chennakeshava Shenoy, Suryakanth Motilal Pai
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bhami's Research Laboratory Private Limited
- Date of Incorporation 25 May, 2013
- Jurisdiction Mangalore, Karnataka, India
-
Annual Revenue
$56.96 K (USD)-67.46as on Mar 31, 2023
-
Net Profit
-$400.74 K (USD)-71.27as on Mar 31, 2023
-
EBITDA
-$258.89 K (USD)-62.78as on Mar 31, 2023
-
Total Equity Funding
$2.41 M (USD)
in 4 rounds
-
Latest Funding Round
$1.14 M (USD), Seed
Jan 27, 2021
-
Investors
Capitalbiologics
& 35 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bhami
Bhami offers a comprehensive portfolio of products and services, including HILOPRO® and Evopep.
A viscosity-reducing platform for monoclonal antibodies is provided to enable high-concentration formulations.
A platform for the oral delivery of biologics is offered, achieving proven bioavailability in in-vivo models.
Funding Insights of Bhami
Bhami has successfully raised a total of $2.41M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.14 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bhami
Bhami has secured backing from 36 investors, including angel investors. Prominent investors backing the company include Capitalbiologics, Anoop Venkat Rao and Prajnya Rao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AV
Anoop Venkat Rao |
-
|
Locked | Locked | Locked |
|
PR
Prajnya Rao |
-
|
Locked | Locked | Locked |
|
CA
Chillakuru Abhirama Reddy |
-
|
Locked | Locked | Locked |
Investor details for Bhami
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bhami
Investment portfolio details for Bhami
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bhami
Detailed financials for Bhami
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bhami Comparisons
Peer comparison for Bhami
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bhami
Detailed competitors of Bhami
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bhami
Complete news archive for Bhami
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhami
Bhami was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Bhami is headquartered in Mangaluru, India. It is registered at Mangaluru, Karnataka, India.
Suryakanth Pai is the current CEO of Bhami. They have also founded this company.
Bhami is a funded company, having raised a total of $2.41M across 4 funding rounds to date.
Annual revenue of Bhami is $56.96K as on Mar 31, 2023.
Bhami Research Laboratories was established in 2013 in Mangaluru, India, as a biotechnology firm. Emphasis is placed on research into high concentration protein formulations that feature reduced viscosity. Operations involve technology development for the biologics sector, including licensing agreements with entities like Catalent. Core activities center on innovations in protein-based solutions for pharmaceutical applications.
Bhami offers HILOPRO® and Evopep.
Bhami has 36 investors. Key investors include Capitalbiologics, Anoop Venkat Rao, Prajnya Rao, Chillakuru Abhirama Reddy, and Raghavendra Kudva.